MedTrace Logo

Modification of Chronic Inflammation by Inhaled Carbon Monoxide in Patients With Stable Chronic Obstructive Pulmonary Disease (COPD)

NCT00122694 · Status: COMPLETED · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2006-09-12

No results posted yet for this study

Summary

The purpose of this study is to determine whether carbon monoxide is effective in the treatment of stable COPD.

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

carbon monoxide

Sponsors & Collaborators

  • Stichting Astma Bestrijding, The Netherlands

    collaborator OTHER

  • Groningen Research Institute for Asthma and COPD

    lead OTHER

Principal Investigators

  • H AM Kerstjens, Prof., MD, PhD · University Medical Center Groningen, Department of Pulmonary Diseases

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-01-31
Completion
2006-03-31

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00122694 on ClinicalTrials.gov